Vassilios Katsos, President & CEO of Pharmathen, articulates the philosophy that has led to the company’s strong market positioning: innovation, internationalization and investment. Based on this triumvirate of strategies, he describes Pharmathen’s ability to keep pace with the global market while maintaining a focus on R&D and operational excellence.
As one of the key staples of the pharmaceutical landscape proudly rooted in Greece, how would you describe Pharmathen’s evolution thus far?
"We account for almost one percent of the total Greek export, which is a testament to the company’s significance to the country."
